Skip to main content

Closed

OKYO: OKYO Pharma Limited Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-74.6%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-20.8×

Current ratio2.43×

OKYO Pharma Limited

OKYONASDAQ Capital Market·USD·Closed

OKYO Pharma Limited

OKYONASDAQ·USD·Closed

$1.68

+1.20%

$1.68

+$0.02 (1.20%)

52W Range

17thpctl

Volume

0.27×avg

Mkt Cap

64.46MUSD

P/E

-8.9TTM

Div Yield

–ann

52W Range

17thpctl

Volume

0.27×avg

Market Cap

64.46MUSD

P/E Ratio

-8.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings